Consolidated Statements of Operations - USD ($) shares in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Statement [Abstract]
Net sales	$ 2,228,000,000	$ 2,322,000,000	$ 2,218,000,000
Cost of sales	(1,798,000,000)	(1,857,000,000)	(1,795,000,000)
Gross profit	430,000,000	466,000,000	423,000,000
Selling, general and administrative expenses	(156,000,000)	(110,000,000)	(110,000,000)
Research, development and engineering expenses, net	(466,000,000)	(375,000,000)	(300,000,000)
Goodwill, impairment charge	0	(234,000,000)	0
Amortization of intangibles	(23,000,000)	(37,000,000)	(35,000,000)
Other income (expense), net	18,000,000	8,000,000	(4,000,000)
Operating loss	(197,000,000)	(283,000,000)	(25,000,000)
Loss from equity method investment	(63,000,000)	(31,000,000)	0
Interest income	7,000,000	0	0
Interest expense	(1,000,000)	0	0
Other non-operating items, net	0	(1,000,000)	3,000,000
Loss before income taxes	(253,000,000)	(314,000,000)	(22,000,000)
Income tax expense	(42,000,000)	(30,000,000)	(38,000,000)
Net loss	(294,000,000)	(344,000,000)	(60,000,000)
Less: Net loss attributable to non-controlling interest	(19,000,000)	(127,000,000)	(7,000,000)
Net loss attributable to controlling interest	$ (276,000,000)	$ (217,000,000)	$ (53,000,000)
Net loss per share - basic (in dollars per share)	$ (3.17)	$ (2.49)	$ (0.61)
Net loss per share - diluted (in dollars per share)	$ (3.17)	$ (2.49)	$ (0.61)
Weighted average number of shares outstanding, (in millions) (in shares)	87,160	87,130	87,130
Weighted average number of shares outstanding, assuming dilution (in millions) (in shares)	87,160	87,130	87,130